PROMETHEUS BIOSCIENCES INC's ticker is RXDX and the CUSIP is 74349U108. A total of 103 filers reported holding PROMETHEUS BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,540 | -2.0% | 14,300 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $1,572 | -99.8% | 14,300 | 0.0% | 0.00% | +100.0% |
| Q3 2022 | $832,000 | +109.0% | 14,300 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $398,000 | -25.9% | 14,300 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $537,000 | +9.8% | 14,300 | +10.0% | 0.00% | 0.0% |
| Q4 2021 | $489,000 | – | 13,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 72 Investment Holdings, LLC | 1,848,024 | $203,282,640 | 93.46% |
| CHI Advisors LLC | 923,800 | $101,618,000 | 27.06% |
| Sio Capital Management, LLC | 574,200 | $63,162,000 | 23.36% |
| Cormorant Asset Management, LP | 2,090,000 | $229,900 | 15.38% |
| Boxer Capital, LLC | 1,897,500 | $208,725,000 | 11.00% |
| SEVEN GRAND MANAGERS, LLC | 20,105 | $2,211,550 | 10.34% |
| Decheng Capital Management III (Cayman), LLC | 250,000 | $27,500,000 | 10.29% |
| Ikarian Capital, LLC | 288,926 | $31,781,860 | 7.67% |
| RTW INVESTMENTS, LP | 3,354,303 | $368,973,330 | 7.53% |
| Waypoint Capital Advisors, LLC | 171,181 | $18,829,910 | 6.53% |